John Markels serves as Executive at SANGAMO THERAPEUTICS, INC, where they oversee executive responsibilities. Since joining the company, John Markels has executed 7 insider transactions totaling $25.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 14, 2024 involved exercising options for 3,131 shares valued at $0.
John Markels currently holds 3,131 shares of SANGAMO THERAPEUTICS, INC (SGMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Markels has been a net buyer of SGMO stock. They have purchased $25.0K and sold $0 worth of shares.
John Markels's most recent insider trade was on Jun 14, 2024, when they sold 3,131 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 1, 2023 | SGMO | $0 | Award | 13,900 | $N/A | Discretionary |
| Jun 3, 2022 | SGMO | $25.0K | Purchase | 6,784 | $3.69 | Discretionary |
| Feb 25, 2022 | SGMO | $0 | Award | 12,500 | $N/A | Discretionary |
| Feb 25, 2021 | SGMO | $0 | Award | 8,200 | $N/A | Discretionary |
| Feb 11, 2020 | SGMO | $0 | Award | 5,000 | $N/A | Discretionary |